Clinical trials
Withdrawn Phase 2 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AHS Cancer Control Alberta | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Cedars-Sinai Medical Center | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| Gilead Sciences | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| ImmunityBio, Inc. | 1 |
| Institut Bergonié | 1 |
| M.D. Anderson Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 19 |
| Breast Neoplasms | 6 |
| Colorectal Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Inflammatory Breast Neoplasms | 1 |
| Sarcoma | 1 |
| Tertiary Lymphoid Structures | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.